![]() |
ExonHit Announces Successful Completion Of The First Phase Of EHT Dx14 Ongoing Clinic
ExonHit Therapeutics (Paris:ALEHT) today announced successful completion of the first phase of the validation study of EHT Dx14, a new transcriptomic signature allowing to differentiate, at molecular level, benign breast tumors from malignant ones...
More... |
| All times are GMT -7. The time now is 08:40 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021